Navigation Links
Spiral constriction -- how dynamin mediates cellular nutrient uptake
Date:9/20/2011

Dr. Katja Flber and Professor Oliver Daumke, structural biologists at the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, together with researchers from Freie Universitt (FU) Berlin, have determined the molecular structure of dynamin, a 'wire-puller' that mediates nutrient uptake into the cell. Since pathogens such as HIV can also enter the body's cells in this way, understanding the underlying molecular mechanisms can potentially open up new approaches for medical applications (Nature, DOI: 10.1038/nature10369)*.

Many nutrients pass from the blood through cell membrane channels into the body cells. However, appropriate channels do not exist for all nutrients. For example, iron binds outside the cell to a large transport molecule and is imported by other means, via endocytosis, into the cell. The cargo-containing transport molecules bind to the cell membrane, which invaginates inward. The iron molecules along with their transporters are taken up in a small membrane bubble (vesicle) into the cell and released there.

An important 'wire-puller' of endocytosis is the protein molecule dynamin. And that in the most literal sense of the word: If a vesicle forms, the dynamin molecules self-assemble and form a spiral around the neck of the vesicle. Dynamin functions like a small motor: It uses the energy of the cell's GTP to pull the spiral together, constricting the neck of the vesicle so that it detaches from the cell membrane.

The molecular details of this 'pull' mechanism around the vesicle neck were previously unknown. In their present study, MDC structural biologists Professor Daumke and Dr. Flber, together with the endocytosis researcher Professor Volker Haucke and the bioinformatician Dr. Frank No of FU Berlin, provide fundamental insights into this process. Using X-ray diffraction analysis, they succeeded in building a structural model of dynamin. For this study it was necessary to produce protein crystals of dynamin. To achieve this, the researchers utilized the insights gained in their previous study about a dynamin-related protein. From the X-ray diffraction pattern of these crystals the researchers were then able to derive a detailed picture of dynamin. "Now that we have an idea of how the dynamin molecule is structured, we can understand at the atomic level how the molecular motor dynamin functions," said Professor Daumke.

In addition to nutrient uptake, endocytosis is also essential for the transmission of signals between neighboring nerve cells and for the immune system. In this way, for example, macrophages engulf pathogens and make them harmless. Professor Daumke: "However, pathogens like HIV and influenza viruses utilize endocytosis to enter our body cells and to spread there. That is why it is important to gain an even more detailed understanding of the molecular 'pull' mechanism of dynamin during endocytosis. Then we can find potential approaches for medical applications especially for patients with muscle and nerve disorders associated with mutations in the dynamin gene." In future research projects funded by the German Research Foundation within the framework of the Collaborative Research Centers (SFB740 and SFB958), the MDC researchers intend to take an even closer look at dynamin. They want to find out what structural changes dynamin accomplishes when the cell's energy carrier GTP binds to the protein and the 'pull' mechanism is set in motion at the vesicle neck.


'/>"/>

Contact: Barbara Bachtler
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert

Related biology news :

1. The cellular intricacies of cystic fibrosis
2. Cellular metabolism self-adapts to protect against free radicals
3. New cellular surprise may help scientists better understand human mitochondrial diseases
4. Cellular laser microsurgery illuminates research in vertebrate biology
5. Cellular stress can induce yeast to promote prion formation
6. Researchers provide means of monitoring cellular interactions
7. Development of a FRET sensor for real-time imaging of intracellular redox dynamics
8. How muscle develops: A dance of cellular skeletons
9. Harvard scientists see the early cellular cause of dry eye disease for the first time
10. Thalidomide shows efficacy as adjuvant therapy for hepatocellular carcinoma patients
11. WSU proves extracellular matrix tugging creates come hither stimulus for cancer migration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology: